Press release
Preeclampsia Diagnosis Market Size 2020 | Detailed research into the regional and competitive dynamics influencing the market growth.
The global preeclampsia diagnosis market size is projected to reach USD 2,165.0 million by 2026, thereby exhibiting a CAGR of 10.7% during the forecast period. However, the market was valued at USD 969.5 million in 2018. This information is published in a recent study by Fortune Business Insights(TM), titled, "Preeclampsia Diagnosis Market Size, Share & Industry Analysis, By Test Type (Blood Tests and Urine Analysis), By Product (Instruments and Consumables) End-user (Hospitals, Specialty Clinics, Diagnostic Centers, and Others) and Regional Forecast, 2019-2026." The study further mentions that the market is expected to gain impetus from the rising economic burden of preeclampsia as well as the increasing adoption of sedentary lifestyle.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/preeclampsia-diagnostics-market-101519
Highlights of the Report
In-depth insights about the preeclampsia diagnosis market trends, growth drivers, hindrances, opportunities, and other related challenges.
Elaborate information regarding the competitive landscape, such as new agreements, partnerships, innovative product launches, contracts, mergers, and acquisitions.
Lists out all the major segments present in the market.
Increasing Incidence of Preeclampsia Worldwide to Drive Growth
The rising incidence of preeclampsia around the world is one of the most crucial factors that is likely to propel the toxemia diagnosis market growth in the coming years. The condition is affecting both neonates and mothers in the developed and developing countries. The World Health Organization (WHO) declared that the prevalence of preeclampsia is seven times higher in the emerging economies as compared to the developed economies. BMC also published a report in its journal. As per the report, the incidence of preeclampsia ranges from 1.8% to 16.7% in the developing countries. It affects approximately 10% of pregnant women in the African continent. Hence, it is extremely higher than the average incidence of around 2% globally.
Diagnostic Centers Segment to Exhibit High Growth Backed by Availability of Novel Instruments
In terms of end-user, the market is grouped into specialty clinics, diagnostic centers, hospitals, and others. Amongst them, the diagnostic centers segment had generated a considerable preeclampsia diagnosis market share previously. This growth is attributable to the presence of novel diagnostic instruments in these centers that are capable of detecting preeclampsia at an early stage. The hospitals segment is anticipated to remain in the second position in terms of market share owing to the rapid improvements in healthcare infrastructure in the emerging countries as well as the rising number of hospitals. Lastly, the specialty clinics segment is set to experience an astonishing growth stoked by the increasing rate of patient visits.
Request a Sample Copy of the Preeclampsia Diagnosis Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/preeclampsia-diagnostics-market-101519
Rising Adoption of Fertility Treatment Options to Favor Growth in Asia Pacific
Geographically, the market is fragmented into North America, Asia Pacific, the Middle East and Africa, Europe, and Latin America. Out of these, North America had generated USD 365.5 million preeclampsia diagnosis market revenue in 2018 and was in the dominating position. This growth is attributable to the rising awareness among the patients and healthcare providers regarding the severity of the condition. Apart from that, increasing healthcare expenditure and adoption of highly advanced products would augment market growth in this region.
Asia Pacific is set to follow the footsteps of North America and remain in the second position owing to the rising utilization of fertility treatment options and high pregnancy rate. Besides, the ever-increasing population and growing awareness campaigns would also lead to growth. Furthermore, industry giants in this region are involving in joint ventures with other renowned companies and diagnostic labs to increase their geographical presence. This, combined with the increasing adoption of technologically advanced products is set to accelerate preeclampsia diagnosis market growth in this region. The Middle East & Africa and Latin America have huge growth potential backed by gradually enhancing healthcare infrastructure, rising disposable income, and increasing prevalence of preeclampsia.
BD Licenses Technology from DiabetOmics to Innovate Testing for Gestational Diabetes & Preeclampsia
February 2016: Becton Dickinson (BD), a medical technology company, headquartered in New Jersey, declared that it is entering into a distribution and licensing agreement for clinical tests from DiabetOmics, Inc., a medical diagnostics company based in the U.S. It has created innovative pregnancy-specific metabolic tests that will support early detection of gestational diabetes and preeclampsia. According to DiabetOmics, the agreement would help in providing access to state-of-the-art tests for women across the globe.
Fortune Business Insights(TM) lists out some of the most prominent organizations operating in the preeclampsia diagnosis market. They are as follows:
Thermo Fisher Scientific Inc.
Bayer AG
Hoffmann-La Roche Ltd.
Siemens Healthineers AG
PerkinElmer Inc.
Sera Prognostics
DRG INSTRUMENTS GMBH
Metabolomic Diagnostics Ltd.
Diabetomics, Inc.
Other key market players
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/preeclampsia-diagnostics-market-101519
Detailed Table of Content:
Introduction
Research Scope
Market Segmentation
Research Methodology
Definitions and Assumptions
Executive Summary
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Key Insights
Prevalence of Preeclampsia by Key Regions
Pricing Analysis by Key Players in Major Regions
Technological Advancements in Preeclampsia Diagnostics
New Test Type Launch by Key Players
Key Industry Developments - Partnerships, Mergers, and Acquisitions
Global Preeclampsia Diagnostics Market Analysis, Insights and Forecast, 2015-2026
Key Findings / Summary
Market Analysis, Insights and Forecast - By Test Type
Blood Tests
Urine Analysis
Market Analysis, Insights and Forecast - By Product
Instruments
Consumables
Market Analysis, Insights and Forecast - By End User
Hospitals
Specialty Clinics
Diagnostic Centers
Others
Market Analysis, Insights and Forecast - By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
TOC Continued....!
Have a Look at Related Reports:
Cardiac Rhythm Management Devices Market - https://www.medgadget.com/2020/02/cardiac-rhythm-management-devices-market-global-share-growth-analysis-segmentation-regional-overview-trends-and-forecast-to-2020-2026.html
Surgical Sutures Market Size 2020 - https://www.medgadget.com/2020/02/surgical-sutures-market-size-2020-rising-geriatric-population-augments-demand-for-surgical-sutures-says-fortune-business-insights.html
2020 - 2026 Antithrombin Market - https://www.medgadget.com/2020/02/2020-2026-antithrombin-market-to-touch-us-725-2-million-global-industry-share-size-future-demand-global-research-top-leading-players-emerging-trends-region.html
2020 - 2025 Intravenous Immunoglobulins Market - https://www.medgadget.com/2020/02/2020-2025-intravenous-immunoglobulins-market-to-touch-us-15789-1-million-global-industry-share-top-leading-players-size-future-demand-global-research-emerging-trends-region.html
Fortune Business Insights(TM) offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights(TM) we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights(TM) Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Preeclampsia Diagnosis Market Size 2020 | Detailed research into the regional and competitive dynamics influencing the market growth. here
News-ID: 1937479 • Views: …
More Releases from Fortune Business Insights

Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…

DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…

Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…

Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Preeclampsia
Emerging Preeclampsia Drugs Market Trends: Leading Companies In The Preeclampsia …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Preeclampsia Drugs Market Size Growth Forecast: What to Expect by 2025?
The market size for drugs used in the treatment of preeclampsia has seen a swift escalation in the recent past. This market is projected to soar from a value of $1.25 billion in 2024 to $1.38 billion in…
Preeclampsia Diagnostics Market Current Status and Future Prospects till 2033
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 8.5% from 2026 to 2033, reaching USD 2.4 Billion by 2033.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
Q1: What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand…
Preeclampsia Drugs Market Report 2025-2034: Industry Overview, Trends, And Forec …
The Preeclampsia Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Preeclampsia Drugs Market Size and Its Estimated Growth Rate?
In recent times, there has been a swift expansion in the market size of drugs for preeclampsia. The market, which is expected…
Preeclampsia Diagnostics Market | Exploring Current Trends and Growth Status for …
Preeclampsia Diagnostics Market size was valued at USD 1.2 Billion in 2022 and is projected to reach USD 2.5 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030.
Preeclampsia Diagnostics Market Outlook and Investment Analysis
What is the current market outlook for Preeclampsia Diagnostics?
The Preeclampsia Diagnostics Market is experiencing growth due to increasing awareness, advancements in diagnostic technologies, and the rising prevalence of preeclampsia globally. Growing demand for…
Preeclampsia Diagnostics Market Forecast Report 2032
Preeclampsia Diagnostics Market By Test Type (Blood Test, Urine Test, Others), By Product & Services (Instruments, Reagents & Consumables, Services), By End-User (Hospitals, Diagnostic Centers, Others) - Growth, Share, Opportunities & Competitive Analysis, 2024 - 2032
The preeclampsia diagnostics market [https://www.acutemarketreports.com/report/preeclampsia-diagnostics-market] is expected to grow at a CAGR of 4.1% during the forecast period of 2024 to 2032. This growth will be driven by developments in the discovery of biomarkers, the…
Preeclampsia Market Size, Share, Trends, Report and Forecast 2024-2032
The preeclampsia market size is anticipated to grow at a CAGR of 1.8% during the forecast period of 2024-2032, driven by advancements in early detection and monitoring along with growing hypertension prevalence across major markets.
Preeclampsia: Introduction
Preeclampsia is a pregnancy complication characterized by high blood pressure and signs of damage to organ systems, often the kidneys. It usually occurs after 20 weeks of pregnancy in women whose blood pressure had been…